Business Wire

Diligent Acquires Brainloop to Expand Governance Cloud Offering with Secure Virtual Data Rooms for the Enterprise

Jaa

Diligent Corporation (“Diligent” or “the Company”), the leader in enterprise governance management and the most trusted provider of secure board collaboration solutions, today announced the completion of its acquisition of Brainloop. Brainloop is the leading supplier of virtual data room software used within the enterprise for high-security collaboration on confidential documents. Headquartered in Munich, Brainloop will become Diligent’s continental European hub and will continue to be led by its current management team, including Chief Executive Officer Thomas Deutschmann and Chief Technology Officer Eike Schmidt. The financial terms of the transaction were not disclosed.

Brainloop is the leading provider of secure cloud storage for enterprises in Germany and throughout continental Europe. Brainloop protects its customers’ most important and sensitive data through high-security applications and delivers efficient solutions for communication, collaboration and the exchange of confidential information. Founded in 2000, Brainloop today serves thousands of users on six continents, including a number of blue-chip European corporations.

As part of Diligent, Brainloop will continue to operate as an independent company and serve its clients under the Brainloop brand, while having the opportunity to leverage Diligent’s robust resources to scale globally. Brainloop will maintain its customers’ data in its existing secure data centers throughout Europe. More than half of Diligent’s revenue is derived outside of the United States, and now, combined with Brainloop, Diligent is the leading secure communication and collaboration tool for enterprises in continental Europe. Together, Diligent and Brainloop will offer a highly complementary product suite to a global base of clients, including Diligent’s industry-leading Governance Cloud offering and Brainloop’s high-security virtual data rooms.

“Diligent is committed to providing the tools that boards and leadership teams need to manage their organizations securely and effectively, and we are excited about this new capability to extend our Governance Cloud offering more broadly across the enterprise,” said Brian Stafford, President and Chief Executive Officer of Diligent.

“We have long respected the trust and sterling reputation in Europe that Thomas and Brainloop have established through their highly secure virtual data room and collaboration solutions. Together, we look forward to bolstering Diligent’s presence in the high-growth DACH region and throughout Europe and offer our clients world-class products at the highest standards of security.”

“Data security and privacy have always been of utmost importance to Brainloop, and we are excited to find a partner in Diligent who cares as deeply about security and client data privacy as we do,” said Thomas Deutschmann, Chief Executive Officer of Brainloop. “Diligent was looking for a virtual data room to scale globally, and we are proud that they found that in Brainloop. We look forward to delivering a broader enterprise governance management solution to our clients, in partnership with the Diligent team.”

District Capital Partners served as the financial advisor, Willkie Farr & Gallagher LLP served as the legal advisor and Spitzberg Partners served as the strategic advisor to Diligent. ARQIS served as the legal, tax and financial advisor to Brainloop.

About Diligent Corporation

Diligent is the leader in Enterprise Governance Management and provides secure corporate governance and collaboration solutions to boards and senior executives through its Governance Cloud offering. Over 14,000 clients in more than 90 countries and on all seven continents rely on Diligent for secure distribution of board materials, as well as secure messaging, integrated compliance, board evaluation and entity management. Governance Cloud is the only solution that meets the evolving governance needs of leading organizations. Visit www.diligent.com to learn more.

About Brainloop

Founded in 2000, Brainloop is a market-leading provider of highly intuitive software-as-a-service (SaaS) solutions. These solutions enable its customers to securely manage and collaborate on confidential documents and information, both within the company and beyond. Brainloop’s customers comprise numerous Fortune, FTSE and DAX companies across a wide range of sectors, both private and public. These customers rely on Brainloop’s regulatory and corporate compliance, collaboration and process capabilities, as well as its complete portfolio of security features. These features include full encryption, audit trail, two-factor authentication, and provider and administrator shielding, combined with a convenient and easy-to-use interface. To learn more, visit http://www.brainloop.com.

Contact information

For Diligent Corporation
Greg Nyhan, 646-215-6884
gnyhan@mww.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Veristat Congratulates Agios Pharmaceuticals on the FDA Approval of TIBSOVO®20.8.2018 11:00Tiedote

Veristat, a full service Clinical Research Organization (CRO), congratulates Agios on the recent FDA approval of TIBSOVO® (ivosidenib) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (R/R AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA approved test. TIBSOVO®, an oral, targeted inhibitor of the IDH1 enzyme, is the first and only FDA-approved therapy for patients with R/R AML and an IDH1 mutation. Veristat is honored to have supported Agios with the preparation of the New Drug Application (NDA) for ivosidenib. We congratulate Agios on the approval of this ground-breaking therapy for patients with this life-threatening malignancy. Veristat began working with Agios on this compound five years ago, providing statistical and medical writing support for their phase I study for ivosidenib which led to the recent approval. Veristat’s support continued through the preparation of the NDA submission. “Over the last fi

Veristat is Recognized on the Inc. 5000 List of America’s Fastest-Growing Private Companies for the 4th Consecutive Year20.8.2018 11:00Tiedote

Veristat, a full service Clinical Research Organization (CRO), proudly announces its recognition once again by Inc. Magazine as one of the 5000 fastest-growing private companies in the United States. Since its first appearance on the list in 2015, Veristat has accelerated its growth in size, geographic reach and ability to successfully guide clinical trials through the development process to regulatory approval. “Veristat’s ability to achieve this national recognition and to remain on this list for 4 consecutive years highlights our sustainability, innovation and unfaltering commitment to consistently delivering the highest quality clinical development and regulatory submission services to our clients,” stated Patrick Flanagan, Chief Executive Officer at Veristat. “The meaningful impact that our teams provide to our clients and to lives of the patients their programs benefit is astounding. In 2018, our teams supported five regulatory submissions that were submitted to the US Food & Dru

Boehringer Ingelheim: New sub-analyses to be presented at ESC Congress 2018 further support positive safety profile of Pradaxa® (dabigatran etexilate)20.8.2018 10:00Tiedote

Boehringer Ingelheim today announced that it will present nine sub-analyses from the RE-DUAL PCITM trial and GLORIATM-AF Registry Program at the upcoming ESC Congress 2018, organised by the European Society of Cardiology, taking place in Munich, Germany on the 25-29 August 2018. The primary data from these studies have contributed to a positive label update for dabigatran etexilate (Pradaxa®) in the European Union (EU). The primary RE-DUAL PCITM trial investigated anticoagulation in patients with non-valvular atrial fibrillation (AF) following percutaneous coronary intervention (PCI) and stent placement. Data showed significantly lower rates of major or clinically relevant non-major bleeding events for dual therapy with dabigatran etexilate when compared to triple therapy with warfarin without compromise on efficacy.1,2 GLORIATM-AF is a large, prospective, observational study program run in over 40 countries worldwide. The primary analysis of nearly 5000 AF patients treated with dabiga

Alipay Launches World’s First Paperless Tax Refund Service in South Korea20.8.2018 06:24Tiedote

Alipay, the world’s leading mobile payment and lifestyle platform operated by Ant Financial Services Group, announced that it has partnered with Global Tax Free (“GTF”), a tax refund agency, to launch the world’s first paperless mobile tax refund function in South Korea. Alipay has consistently been at the forefront of innovation that supports mobile tax refund solutions globally. In early 2017, Alipay initiated a real-time tax refund service in Europe which enabled users to instantly receive tax rebates in their Alipay accounts after scanning their Alipay QR code at airport tax counters. The newly introduced tax refund service in South Korea further simplifies the process by enabling Chinese tourists to apply for and claim tax rebates on their mobile phone app, skipping in-city and airport tax refund counters altogether. After scanning their passports at self-service kiosks prior to leaving South Korea, Chinese tourists can process tax rebates and immediately receive RMB refunds by us

Manchester United Shoots for Success with a “Digital Experience Platform” Powered by HCL16.8.2018 22:02Tiedote

Manchester United (NYSE:MANU) has today announced a major milestone on its digital transformation journey with HCL Technologies, with the successful launch of the Manchester United Official app powered by HCL’s digital experience platform. The launch is part of the ongoing digital transformation of the club to provide a real-time, engaging, personalized, and unified experience to Manchester United’s 659 million global followers, which supports the club’s strategy to become a Digital Sports Enterprise. At the heart of this transformation is the digital platform developed by HCL, providing the club with a single view of fans across web and app touchpoints, offering fans a one-stop shop for everything Manchester United. Manchester United’s Group Managing Director Richard Arnold comments: “This app will allow our 659 million Manchester United followers to easily connect to the club they love, wherever they are in the world. Fans will now have the opportunity to follow all Manchester United

4K 4Charity Fun Run Announces Open Registration for IBC201816.8.2018 20:41Tiedote

AWS Elemental, an Amazon Web Services (AWS) company, today announced that the fifth annual 4K 4Charity Fun Run at IBC Show will take place at 7:00 a.m. local time on Saturday, Sept. 15 at Amstelpark in Amsterdam. Registration is open at https://4k4charity.com/ibc. Among the non-profits supported by the 4K 4Charity Fun Run at IBC Show is Amsterdam-based StichtingNewTechKids, which provides computer science education for girls, minorities, and economically challenged youth in the Netherlands. The organization supports a computer science teacher training program for primary school teachers with proceeds from 4K 4Charity. Also supported is Iridescent, a global education non-profit that empowers underrepresented young people to become innovators and leaders through engineering and technology. Through their two programs, Curiosity Machine AI Family Challenge and Technovation, Iridescent introduces underserved communities to new technologies and empowers and equips them to apply those technol

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme